Medicine guide

Qdenga

·

  • Prescription status not stated
  • Antibiotics, antivirals and antifungals taken into the body
Made by
Takeda Pharmaceuticals International AG Ireland Branch

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. The use of Qdenga should be in accordance with official recommendations.

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byTakeda Pharmaceuticals International AG Ireland Branch
Active substanceDengue tetravalent vaccine (live, attenuated)
Used inAntibiotics, antivirals and antifungals taken into the body
ClassificationJ07BX04 · Antibiotics, antivirals and antifungals taken into the body
Additional monitoring ▼Yes — under additional monitoring (black triangle). Report suspected side effects.
Authorised on2022-12-05
Last updated by the regulator2026-09-04
EMA product numberEMEA/H/C/005155

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.